BCG vaccination induces antibacterial effector functions among Vδ1/3 T cells that are associated with protection against tuberculosis

Megan D. Maerz, Mohau S. Makatsa, Allison N. Bucsan, Matthew S. Sutton, Emma Bishop, Ziwei Tian, Erik D. Layton, Mario Roederer, Alex K. Shalek, Robert A. Seder, Thomas J. Scriba, Chuangqi Wang, Patricia A. Darrah, and Chetan Seshadri

DOI: https://doi.org/10.1016/j.xcrm.2025.102536

γδ T cells expressing a Vδ1/3+ T cell receptor are enriched at mucosal surfaces, but their role in protection against Mycobacterium tuberculosis (Mtb) is largely unknown. We used multimodal single-cell RNA sequencing, mass cytometry, and flow cytometry to profile γδ T cells from human infants and macaques after protective vaccination with Mycobacterium bovis bacillus Calmette Guerin (BCG). A subset of Vδ1/3 T cells in BCG-vaccinated human infants shows evidence of clonal expansion and differentiation into Mtb-reactive cytotoxic effector cells. In macaques, intravenous BCG induces pro-inflammatory and cytotoxic responses to Mtb among Vδ1/3 T cells that are enriched in the airway compared to the blood. Finally, the frequency of cytokine-expressing Vδ1/3 T cells in the airway is associated with protection against Mtb challenge. Thus, Vδ1/3 T cells are activated by BCG and accumulate in the lung, where they upregulate cytotoxic and pro-inflammatory functions that may contribute to protective immunity against Mtb.

SEEK ID: https://fairdomhub.org/studies/1421

IMPAcTB

Projects: Hi-IMPAcTB

Study position:

help Creators and Submitter
Activity

Views: 1635

Created: 18th Nov 2025 at 00:13

Last updated: 4th Mar 2026 at 15:37

help Tags

This item has not yet been tagged.

Powered by
(v.1.18.4)